In vitro fertilization treatment in patients with polycystic ovaries

[1]  S. Lipitz,et al.  Polycystic ovarian syndrome: pregnancy outcome following in vitro fertilization-embryo transfer. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  R. Norman,et al.  Endocrinology: Immunoactive interleukin-1β and tumour necrosis factor-α in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries , 1995 .

[3]  G. Lefèbvre,et al.  How many embryos should be transferred in in vitro fertilization? A prospective randomized study. , 1994, Fertility and sterility.

[4]  A. Lanzone,et al.  Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. , 1994, Fertility and sterility.

[5]  Z. Ben-Rafael,et al.  In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. , 1993, Fertility and sterility.

[6]  S. L. Tan,et al.  A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. , 1993, Human reproduction.

[7]  D. Magoffin,et al.  Granulosa cells of polycystic ovaries: are they normal or abnormal? , 1992, Human reproduction.

[8]  J. Dor,et al.  The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study. , 1992, Fertility and sterility.

[9]  E. Rudak,et al.  The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.

[10]  A. Lucky,et al.  Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome , 1990 .

[11]  J. Eden,et al.  FOLLICULAR FLUID CONCENTRATIONS OF INSULIN‐LIKE GROWTH FACTOR 1, EPIDERMAL GROWTH FACTOR, TRANSFORMING GROWTH FACTOR‐ALPHA AND SEX‐STEROIDS IN VOLUME MATCHED NORMAL AND POLYCYSTIC HUMAN FOLLICLES , 1990, Clinical endocrinology.

[12]  J. Adams,et al.  Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. , 1988, BMJ.

[13]  K. Fredga,et al.  Ploidy in human cleavage stage embryos after fertilization in vitro. , 1987, Human reproduction.

[14]  R. Edwards,et al.  EFFECT OF HIGH TONIC LEVELS OF LUTEINISING HORMONE ON OUTCOME OF IN-VITRO FERTILISATION , 1986, The Lancet.

[15]  E. Porcu,et al.  Comparison Between Human Urinary Follicle‐Stimulating Hormone and Human Menopausal Gonadotropin Treatment in Polycystic Ovary , 1984, Obstetrics and gynecology.

[16]  J. Halme,et al.  Factors Affecting the Pregnancy Rate in Clomiphene Citrate Induction of Ovulation , 1983, Obstetrics and gynecology.

[17]  D. Mishell,et al.  Clinical and laboratory predictors of clomiphene response. , 1982, Fertility and sterility.

[18]  Hughes Pe.  Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis” , 1982 .

[19]  C. Gemzell,et al.  The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. , 1980, Fertility and sterility.

[20]  M. J. Whitelaw,et al.  The significance of the high ovulation rate versus the low pregnancy rate with Clomid. A review of 203 private anovulatory patients. , 1970, American journal of obstetrics and gynecology.

[21]  R. Norman,et al.  Immunoactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries. , 1995, Human reproduction.

[22]  A. Lucky,et al.  Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. , 1990, Fertility and sterility.

[23]  P. Hughesdon.  Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". , 1982, Obstetrical & gynecological survey.